The strong Q3 beat and raised guidance signal accelerating momentum in the core NOP business ahead of ENHANCE Heart Part B and DENOVO Lung catalysts. Monitor the Q4 call for initial enrollment updates on these trials and European NOP launch progress.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $88.24entry
- T+1 · 8d ago +6.29%α +3.92% · $93.79
- T+5 · 4d ago +3.56%α +0.96% · $91.38
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
TransMedics reported Q3 2026 revenue of $203.0M (+41% YoY) and GAAP EPS of $0.46, beating consensus estimates of $177.1M and $0.29. The company raised full-year 2026 revenue guidance to $764-$774M (including PAD Aviation), up from prior guidance of $737-$757M, driven by record case volume and strong execution in the National OCS Program.
Key Financial Metrics
Key Facts
- Q3 2026 total revenue of $203.0M, up 41% YoY from $143.8M
- GAAP diluted EPS of $0.46 vs consensus $0.29 (beat by 58.6%)
- Adjusted diluted EPS of $0.51 vs consensus $0.29 (beat by 75.9%)
- Full-year 2026 revenue guidance raised to $764-$774M from $737-$757M
- Organic revenue growth (ex-PAD Aviation) was 34.6% in Q3
- Service revenue grew 60% YoY to $89.6M; organic service revenue growth was 42.8%
- Operating income of $28.1M, up 21% YoY; operating margin 13.9%
- Cash balance of $493.0M as of September 30, 2026
- Received FDA IDE approvals for ENHANCE Heart Part B and DENOVO Lung trials in October
- Awarded first European transplant logistics tender in Italy
Financial Impact
Revenue beat consensus by $25.9M (14.6%); EPS beat by $0.17 (58.6%); guidance raised by $27M at midpoint
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Net product revenue | $113.4M | +29.0% |
| Service revenue | $89.6M | +60.0% |
Risk Factors
- GAAP net income declined YoY ($17.1M vs $24.3M) due to higher operating expenses and interest costs
- Operating margin contracted 230bps YoY to 13.9% as investments in R&D and infrastructure outpace revenue growth
- Diluted share count increased to 40.8M from 40.7M YoY, pressuring per-share metrics
- PAD Aviation contributed $9.4M in Q3 revenue; integration and profitability trajectory remain unproven
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-449729 |
| Document: tmdx-20261105.htm | 0001193125-26-449729 |
| Document: 0001193125-26-449729-index-headers.html | 0001193125-26-449729 |
| Document: 0001193125-26-449729-index.html | 0001193125-26-449729 |
| Document: 0001193125-26-449729.txt | 0001193125-26-449729 |
| 8-K Data (Synthetic) | 0001193125-26-449729 |
Track record
9 reports on TMDX
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +22.27% at T+60 after the Jun 11, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $90.95 Now $92.21 +1.39% settles Nov 17
- Nov 5, 202611d ago 8-K Bullish 6/10 Viewing Entry $88.24 to $91.38 Now $92.21 +4.50% ▲ +3.56% +0.96% vs SPY
- Nov 5, 202611d ago Press Release Bullish 6/10 No price data
- Jun 12, 202622w ago Institutional Cluster Bullish 6/10 Entry $72.91 to $78.79 Now $92.21 +26.47% ▲ +8.06% +7.39% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bullish 5/10 Entry $73.59 to $73.22 Now $92.21 +25.30% ▼ −0.50% −0.94% vs SPY
- Apr 10, 202631w ago DEFA14A Neutral 3/10 Entry $114.00 to $115.87 Now $92.21 −19.11% ▲ +1.64% −2.86% vs SPY
- Mar 2, 202637w ago Insider Cluster Neutral 3/10 Entry $147.00 to $134.77 Now $92.21 −37.27% ▼ −8.32% −7.11% vs SPY
- Feb 27, 202637w ago 8-K Neutral 4/10 Entry $145.26 to $129.61 Now $92.21 −36.52% ▼ −10.77% −8.79% vs SPY
- Feb 24, 202637w ago 8-K Bullish 8/10 Entry $131.85 to $147.66 Now $92.21 −30.06% ▲ +11.99% +13.09% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers